These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 20080367)

  • 1. High throughput analysis of drugs of abuse in hair by combining purposely designed sample extraction compatible with immunometric methods used for drug testing in urine.
    de la Torre R; Civit E; Svaizer F; Lotti A; Gottardi M; Miozzo M
    Forensic Sci Int; 2010 Mar; 196(1-3):18-21. PubMed ID: 20080367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of hair analyses for drugs of abuse and comparison with self-reports and urine tests.
    Musshoff F; Driever F; Lachenmeier K; Lachenmeier DW; Banger M; Madea B
    Forensic Sci Int; 2006 Jan; 156(2-3):118-23. PubMed ID: 16410161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the IDS One-Step ELISA kits for the detection of illicit drugs in hair.
    Pujol ML; Cirimele V; Tritsch PJ; Villain M; Kintz P
    Forensic Sci Int; 2007 Aug; 170(2-3):189-92. PubMed ID: 17628371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of drugs of abuse in hair: evaluation of the immunochemical method VMA-T vs. LC-MS/MS or GC-MS.
    Baumgartner MR; Guglielmello R; Fanger M; Kraemer T
    Forensic Sci Int; 2012 Feb; 215(1-3):56-9. PubMed ID: 22019396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semi-quantitative analysis of drugs of abuse, including tetrahydrocannabinol in hair using aqueous extraction and immunoassay.
    Coulter C; Tuyay J; Taruc M; Moore C
    Forensic Sci Int; 2010 Mar; 196(1-3):70-3. PubMed ID: 20079985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buprenorphine detection in hair samples by immunometric screening test: preliminary experience.
    Svaizer F; Lotti A; Gottardi M; Miozzo MP
    Forensic Sci Int; 2010 Mar; 196(1-3):118-20. PubMed ID: 20080369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hair testing for drugs of abuse.
    Karacić V; Skender L
    Coll Antropol; 2003 Jun; 27(1):263-9. PubMed ID: 12974155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gas chromatography-mass spectrometry assay for the simultaneous quantification of drugs of abuse in human placenta at 12th week of gestation.
    Joya X; Pujadas M; Falcón M; Civit E; Garcia-Algar O; Vall O; Pichini S; Luna A; de la Torre R
    Forensic Sci Int; 2010 Mar; 196(1-3):38-42. PubMed ID: 20056364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation between drug use and environmental contamination when testing for drugs in hair.
    Tsanaclis L; Wicks JF
    Forensic Sci Int; 2008 Mar; 176(1):19-22. PubMed ID: 17980987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hair analysis for illicit drugs by using capillary zone electrophoresis-electrospray ionization-ion trap mass spectrometry.
    Gottardo R; Bortolotti F; De Paoli G; Pascali JP; Miksík I; Tagliaro F
    J Chromatogr A; 2007 Aug; 1159(1-2):185-9. PubMed ID: 17240388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous detection of seventeen drugs of abuse and metabolites in hair using solid phase micro extraction (SPME) with GC/MS.
    Aleksa K; Walasek P; Fulga N; Kapur B; Gareri J; Koren G
    Forensic Sci Int; 2012 May; 218(1-3):31-6. PubMed ID: 22047752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of an analytical method for the simultaneous determination of cocaine and its main metabolite, benzoylecgonine, in human hair by gas chromatography/mass spectrometry.
    Barroso M; Dias M; Vieira DN; Queiroz JA; López-Rivadulla M
    Rapid Commun Mass Spectrom; 2008 Oct; 22(20):3320-6. PubMed ID: 18819113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hair analysis of abused and therapeutic drugs in forensic toxicology].
    Klausz G; Kass K; Sótonyi P; Róna K
    Orv Hetil; 2006 Nov; 147(45):2181-6. PubMed ID: 17402212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization and validation of CEDIA drugs of abuse immunoassay tests in serum on Hitachi 912.
    Kirschbaum KM; Musshoff F; Schmithausen R; Stockhausen S; Madea B
    Forensic Sci Int; 2011 Oct; 212(1-3):252-5. PubMed ID: 21775079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four years' experience in external proficiency testing programs for hair testing of drugs of abuse in Italy (HAIRVEQ) and comparison with the Society of Hair Testing program in 2005.
    Ventura M; Pichini S; Pujadas M; Ventura R; Di Giovannandrea R; Zuccaro P; Pacifici R; Langohr K; Jurado C; de la Torre R
    Ther Drug Monit; 2007 Feb; 29(1):11-9. PubMed ID: 17304145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous screening and quantification of 52 common pharmaceuticals and drugs of abuse in hair using UPLC-TOF-MS.
    Nielsen MK; Johansen SS; Dalsgaard PW; Linnet K
    Forensic Sci Int; 2010 Mar; 196(1-3):85-92. PubMed ID: 20061098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The standardization of results on hair testing for drugs of abuse: An interlaboratory exercise in Lombardy Region, Italy.
    Stramesi C; Vignali C; Groppi A; Caligara M; Lodi F; Pichini S; Jurado C
    Forensic Sci Int; 2012 May; 218(1-3):101-5. PubMed ID: 22018743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of opiates and cocaine in hair using automated enzyme immunoassay screening methodologies followed by gas chromatographic-mass spectrometric (GC-MS) confirmation.
    Lachenmeier K; Musshoff F; Madea B
    Forensic Sci Int; 2006 Jun; 159(2-3):189-99. PubMed ID: 16203118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A proficiency test for hair analysis in detecting drug abuse as an index of the quality of toxicologic analysis].
    Rojek S; Kłys M; Scisłowski M
    Arch Med Sadowej Kryminol; 2005; 55(3):195-205. PubMed ID: 16320768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of screening immunoassays to detect sub-threshold concentrations of cocaine, cannabinoids, and opiates in urine: use for detecting maternal and neonatal drug exposures.
    Hattab EM; Goldberger BA; Johannsen LM; Kindland PW; Ticino F; Chronister CW; Bertholf RL
    Ann Clin Lab Sci; 2000 Jan; 30(1):85-91. PubMed ID: 10678589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.